Akari Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.About AKTX
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.
CEORachelle Jacques
CEORachelle Jacques
Employees15
Employees15
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2004
Founded2004
Employees15
Employees15
AKTX Key Statistics
Market cap9.44M
Market cap9.44M
Price-Earnings ratio-0.27
Price-Earnings ratio-0.27
Dividend yield—
Dividend yield—
Average volume16.86K
Average volume16.86K
High today$1.90
High today$1.90
Low today$1.72
Low today$1.72
Open price$1.89
Open price$1.89
Volume13.38K
Volume13.38K
52 Week high$5.50
52 Week high$5.50
52 Week low$1.66
52 Week low$1.66